Showing 281 - 300 results of 64,227 for search '(( 5 ((mg decrease) OR (we decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.14s Refine Results
  1. 281
  2. 282

    Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

    Published 2016
    “…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”
  3. 283
  4. 284
  5. 285
  6. 286
  7. 287
  8. 288

    Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis by Yan Sun (22436)

    Published 2020
    “…The number of catheters removed due to infection or suspected infection was not significantly different between the two groups (RR: 0.68; 95% CI:0.22, 2.10; I<sup>2</sup> = 56%; P = 0.50) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0231110#pone.0231110.g005" target="_blank">Fig 5</a>). …”
  9. 289

    A Yoga Strengthening Program Designed to Minimize the Knee Adduction Moment for Women with Knee Osteoarthritis: A Proof-Of-Principle Cohort Study by Elora C. Brenneman (795723)

    Published 2015
    “…A secondary objective was to determine whether the program could improve mobility and fitness, and decrease peak KAM during gait. …”
  10. 290
  11. 291
  12. 292
  13. 293
  14. 294
  15. 295
  16. 296
  17. 297
  18. 298

    Validation of a New Scoring Scale for Behavioral Assessment of L‑Dopa-Induced Dyskinesia in the Rat: A New Tool for Early Decision-Making in Drug Development by Simon Loiodice (4715610)

    Published 2017
    “…Unilaterally 6-OHDA-lesioned rats were administered L-dopa (20 mg/kg) and benserazide (5 mg/kg) daily for 3 weeks starting 4 weeks postlesion, then coadministered with amantadine (20–30–40 mg/kg). …”
  19. 299

    S3 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
  20. 300

    S2 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects: